Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Interim guidance on the use of pneumococcal 15-valent conjugate vaccine in pediatric populations in Canada: NACI, March 21, 2023 - Canada.ca Français fr / Search Search Canada.ca Search Menu…

Vaccination Coverage Goals and Vaccine Preventable Disease Reduction Targets by 2025 - Canada.ca Français fr / Search Search Canada.ca Search Jobs and the workplace…

Update on the use of pneumococcal vaccines in adults 65 years of age and older – A Public Health Perspective - Canada.ca Français fr / Search Search Canada.ca Search Jobs and…

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: NACI recommendations: Economic evidence supplementary appendixrecommendations. - Canada.ca Français fr /…

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Summary of NACI Statement of February 2023 - Canada.ca Français fr / Search Search…

Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca Français fr / Search Search…

Summary: Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca Français fr / Search Search Canada.ca Search Jobs and the…

Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca Français fr / Search Search Canada.ca Search Jobs and the workplace…

Page 2397 of 2498Showing 23961-23970 of 24974

Early release: coverage and features are still expanding.